Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular and Clinical Oncology|November 24, 2025
Drug resistance in glioblastoma: Challenges, mechanisms and therapeutic strategies (Review)Yash K Durga, Raju V PusapatiCell Cycle (Georgetown, Tex.)|April 4, 2006
Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosisSungki Hong, Raju V Pusapati, John T Powers, et al.Cancer Research|February 4, 2010
Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependencyUltan McDermott, Raju V Pusapati, James G Christensen, et al.Molecular Carcinogenesis|October 3, 2009
E2F2 suppresses Myc-induced proliferation and tumorigenesisRaju V Pusapati, Regina L Weaks, Robert J Rounbehler, et al.Cancer Cell|April 8, 2016
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer CellsRaju V Pusapati, Anneleen Daemen, Catherine Wilson, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
ATM promotes apoptosis and suppresses tumorigenesis in response to MycRaju V Pusapati, Robert J Rounbehler, SungKi Hong, et al.Pageof 1